Clinical Trials for Uterine Cancer

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers

You do not have JavaScript enabled. This site works better with JavaScript turned on.